DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 10Dr. Reddy's Laboratories
02 2Breckenridge Pharmaceutical
03 2NanoAlvand
04 1medac
05 13Accord healthcare
06 2Accure Labs
07 2Actavis Inc
08 2Adcock Ingram
09 4Alphapharm PTY Ltd
10 3Apotex Inc
11 6Astellas Pharma
12 2Auro Pharma Inc
13 2Aurobindo Pharma Limited
14 1Aurogen South Africa (Pty) Ltd
15 1Azurity Pharma
16 1Baxter Healthcare Corporation
17 2Biem Ilac San. ve Tic. A.S
18 5CEPHALON INC
19 2Capstone Development Services
20 1Chemi SpA
21 2CinnaGen
22 2Clinigen Group
23 2Cps Cito Pharma Services Gmbh
24 1Dr Reddy's Laboratories (Pty) Ltd
25 2EG SpA
26 1ELC Group
27 1EUGIA PHARMA INC.
28 2Eagle Pharmaceuticals
29 2Eriochem S.A.
30 1Fresenius Kabi AB Brunna
31 2Fresenius Kabi Oncology Limited
32 1Fresenius Kabi USA
33 1GetWell Pharmaceutical
34 2Glenmark Pharmaceuticals
35 2Hetero Drugs
36 5Hospira, Inc.
37 2Innopharma Inc
38 1Jodas Expoim Pvt. Ltd
39 4Juno Pharmaceuticals Pty Ltd
40 1Karo Pharma
41 4Kiara Health
42 2MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH
43 2Meitheal Pharmaceuticals
44 2Nang Kuang Pharmaceutical Co. Ltd.
45 2Naprod Life Sciences
46 1Natco Pharma
47 2Natco Pharma (Canada) Inc
48 1ORIFARM GROUP AS
49 2PHARMOBEDIENT
50 1Panacea Biotec Limited
51 1Pfizer Inc
52 1SEACROSS PHARMACEUTICALS
53 1Sakar Healthcare
54 7Sandoz B2B
55 2Teva Pharmaceutical Industries
56 2TherDose Pharma
57 2Vama Lifecare
58 3Viatris
59 1Vinkem Labs Ltd
60 1XYZ Pharma
Reset all filters
01 4Bendamustina 100Mg 5 Units Parenteral Use
02 1Bendamustina 25Mg 20 Joined The Parenteral Use
03 4Bendamustina 25Mg 5 Units Parenteral Use
04 2Concentrate For Solution For Infusion
05 1FREEZE-DRIED POWDER
06 1INF
07 1INJECTABLE; INJECTION
08 4INJECTION
09 1Infusion
10 2Injectable
11 14Injection
12 1Liquid Injection
13 1Lyo.Inj
14 1Lyophilised Injection
15 1Lyophilized Injection
16 2Lyophilized Powder for Solution for Infusion
17 11POI
18 11POWDER FOR SOLUTION
19 18POWDER;INTRAVENOUS
20 8POWDER;IV (INFUSION)
21 16Powder For Concentrate For Solution For Infusion
22 8Powder to concentrate to the infusion fluid, resolution
23 1SOLUTION
24 12SOLUTION;INTRAVENOUS
25 1SOLUTION;IV (INFUSION)
26 2Vial
27 12Blank
Reset all filters
01 7Allowed
02 5Approved
03 14DISCN
04 6Deregistered
05 19Generic
06 1Lead Market Dossiers- Approved in EU
07 4Lead Market Dossiers- Filed
08 2Lead Market Dossiers- Tentative\nApproved in US
09 15RX
10 68Blank
Reset all filters
01 1BELRAPZO
02 32BENDAMUSTINE HYDROCHLORIDE
03 7BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
04 1BENDAWEL
05 1BENDEKA
06 1BENVYON
07 1Baximo 100 mg
08 1Baximo 25 mg
09 2Beastin
10 1Bendahet 100
11 1Bendahet 25
12 3Bendamustin Actavis
13 6Bendamustina
14 1Bendamustine 180mg/4ml DRL
15 6Bendamustine Accord
16 1Bendamustine Accord liquid
17 1Bendamustine Elc
18 3Bendamustine Fresenius Kabi
19 4Bendamustine Juno
20 1Bendamustine Medac
21 7Bendamustine Sandoz
22 4Bendamustine Viatris
23 1Bendamyl
24 4Bendanit
25 2ERIOTIB
26 1Equiben 100
27 1Equiben 25
28 5Levact
29 1Mustinal
30 2NAT-BENDAMUSTINE
31 1Omuben 100mg
32 2Ribomustin
33 2Ribomustin 100 mg
34 2Ribomustin 25 mg
35 2Ribovact
36 2THERMUSTINE
37 7TREANDA
38 1VIVIMUSTA
39 19Blank
Reset all filters
01 2Argentina
02 12Australia
03 12Canada
04 21India
05 4Iran
06 9Italy
07 8Norway
08 12South Africa
09 11Sweden
10 7Switzerland
11 2Turkey
12 40USA
13 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Bendamustine Medac
Dosage Form : Powder For Concentrate For Solution For Infusion
Dosage Strength : 2.5mg/ml
Packaging :
Approval Date : 10/03/2016
Application Number : 20150730000024
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2022-12-07
Application Number : 205376
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 100MG/4ML (25MG/ML)
Packaging :
Approval Date : 2025-07-03
Application Number : 219014
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 45MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
Brand Name :
Dosage Form : Infusion
Dosage Strength : 180MG/4ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in EU
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BENDAMUSTINE HYDROCHLORIDE
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2023-02-14
Application Number : 205447
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Iran
Brand Name : Bendanit
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2008-03-20
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TREANDA
Dosage Form : POWDER;INTRAVENOUS
Dosage Strength : 25MG/VIAL
Packaging :
Approval Date : 2009-05-01
Application Number : 22249
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 45MG/0.5ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TREANDA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 180MG/2ML (90MG/ML)
Packaging :
Approval Date : 2013-09-13
Application Number : 22249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : TREANDA
Dosage Form : INJECTABLE; INJECTION
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 22303
Regulatory Info :
Registration Country : USA